The Commission proposed stronger safeguards for workers exposed to hazardous substances. The measures are expected to prevent around 1,700 lung cancer cases and 19,000 other serious illnesses over the next 40 years. In the sixth revision of the Carcinogens, Mutagens and Reprotoxic substances Directive (CMRD), the Commission recommends setting exposure limits for cobalt and inorganic cobalt …
The European Commission launched two initiatives under its Preparedness Union agenda: an EU Stockpiling Strategy and a Medical Countermeasures Strategy. Both are designed to improve access to essential goods for European citizens and societies, businesses and economies – ensuring continuity of essential goods and lifesaving medical supplies at all times, in particular during crises such as major energy blackouts, …
Healthcare professionals will be able to receive instructions for use of medical devices in electronic format, rather than solely on paper, following a regulation of the European Commission presented. The regulation applies to all medical devices used by healthcare professionals within the EU. Professionals can still request paper versions if preferred. The adoption of electronic …
As part of the COMBINE programme, the European Commission and EU Member States have launched a pilot project to test a new, more efficient way of approving combined studies. These studies involve both clinical trials of medicines and performance studies of medical devices. This pilot is designed to allow sponsors of combined studies to submit …
The Commission invites health stakeholders to submit proposals for a new cycle of Thematic Networks under the EU Health Policy Platform. The deadline for submissions is 22 August 2025. The Thematic Networks are intended to boost collaboration with stakeholder organisations and produce a Joint Statement expressing their position and proposing actions on one of the following …
The European Commission is making available €145.5 million to empower small and medium-sized enterprises and public administrations in deploying cybersecurity solutions and adopting the results of cybersecurity research. For this purpose, the European Cybersecurity Competence has launched two calls for proposals. The first call is part of the Digital Europe Programme, with a budget of €55 million. €30 …
The Commission has restricted the use of chemical substances N,N-dimethylacetamide (DMAC) and 1-ethylpyrrolidin-2-one (NEP) to protect workers from their exposure. DMAC and NEP are solvents used in many industrial processes, including the production of chemicals, coatings, cleaning agents and fibres. DMAC is commonly used in making synthetic fibres and varnishes for electrical wires, while NEP is …
The European Commission launched an online public consultation on joint clinical assessments of medical devices and in vitro diagnostic medical devices at Union level under the HTA Regulation. This online consultation will be open for responses until 25 June 2025. This public consultation is focussed on the last implementing act for adoption under the HTA Regulation, which will complete the …
To strengthen Europe’s vaccine readiness and responsiveness in times of pandemics, the European Vaccine Hub (EHV) was inaugurated in Siena. The initiative consist of key actions, that will amongst others, speed-up vaccine development to less than four months from identifying a pathogen’s genomic sequence. The Hub will bring together nationally-funded vaccine research and development investments at EU …
The Commission welcomes the preliminary consensus on the Pandemic Agreement, by the Intergovernmental Negotiating Body, underscoring the continuing strength of international cooperation and solidarity for global heath. After three years of intensive negotiations the agreement reached marks a significant contribution to strengthening capacities for pandemic prevention, preparedness, and response taking a One Health approach. This is a …